Table 4.
Tapentadol ER N = 46 |
ADF ER Opioids N = 5,313 |
Non-ADF ER Opioids N = 7,192 |
||||
---|---|---|---|---|---|---|
ROA | Estimate | 95% CI | Estimate | 95% CI | Estimate | 95% CI |
Swallow whole | 58.70 | 38.68–85.70 | 53.81 | 52.48–55.18 | 34.99 | 33.90–36.12 |
Other oral | 17.39 | 7.50–34.26 | 23.50 | 22.39–24.68 | 11.30 | 10.59–12.06 |
Inject | 10.87 | 3.52–25.33 | 26.08 | 24.92–27.29 | 42.85 | 41.71–44.02 |
Snort | 2.17 | 0.06–12.11 | 29.30 | 28.09–30.55 | 38.95 | 37.83–40.10 |
Other | 8.70 | 2.37–22.26 | 3.51 | 3.04–4.04 | 5.04 | 4.56–5.58 |
Smoke | 0.00 | 0.00–0.00 | 3.37 | 2.92–3.90 | 1.25 | 1.02–1.54 |
ADF = abuse-deterrent formulation; CI = confidence interval; ER = extended-release; ROA = route of administration.